Compare INBK & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INBK | RXST |
|---|---|---|
| Founded | 1999 | 1997 |
| Country | United States | United States |
| Employees | 355 | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.2M | 232.2M |
| IPO Year | N/A | 2021 |
| Metric | INBK | RXST |
|---|---|---|
| Price | $26.64 | $5.96 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 10 |
| Target Price | ★ $23.25 | $9.78 |
| AVG Volume (30 Days) | 26.8K | ★ 1.1M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $134,479,000.00 |
| Revenue This Year | $279.34 | N/A |
| Revenue Next Year | $12.97 | $10.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.05 | $4.48 |
| 52 Week High | $28.88 | $13.22 |
| Indicator | INBK | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 59.17 | 59.26 |
| Support Level | $25.23 | $5.90 |
| Resistance Level | $28.88 | $6.53 |
| Average True Range (ATR) | 0.91 | 0.37 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 100.00 | 80.94 |
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.